Literature DB >> 2307796

Assessment of the intrapulmonary ventilation-perfusion distribution after the Fontan procedure for complex cardiac anomalies: relation to pulmonary hemodynamics.

T Matsushita1, H Matsuda, M Ogawa, K Ohno, T Sano, S Nakano, Y Shimazaki, K Nakahara, J Arisawa, T Kozuka.   

Abstract

In 12 patients who underwent the Fontan procedure for complex cardiac anomalies, lung scanning with xenon-133 was performed to assess the intrapulmonary ventilation-perfusion distribution, and comparison was made with a control group. All data were then analyzed in relation to either pre- or postoperative pulmonary hemodynamic data. In ventilation scans, the intrapulmonary distribution in the right lung was almost normal. In perfusion scans, an abnormal increased upper to lower lobe perfusion ratio greater than the normal value found in the control group was noted in seven patients (58.3%). There was a significant correlation (p less than 0.02) between the upper to lower lobe perfusion ratio and postoperative pulmonary vascular resistance. Furthermore, this perfusion ratio correlated inversely with the preoperative (p less than 0.005) and postoperative (p less than 0.02) right pulmonary artery area index, defined as the ratio of cross-sectional area to the normal value. Of five patients with less than 90% arterial oxygen saturation, four showed an abnormal distribution of pulmonary blood flow greater than the normal perfusion ratio. No patient had evidence of a pulmonary arteriovenous fistula by the echocardiographic contrast study. These results suggest that abnormal distribution of pulmonary blood flow to the upper lung segment may develop in patients after the Fontan procedure, and that insufficient size of the pulmonary artery before operation and the consequent postoperative elevation of pulmonary vascular resistance may be responsible for this perfusion abnormality.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2307796     DOI: 10.1016/0735-1097(90)90284-v

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

1.  Pulmonary blood flow distribution after the total cavopulmonary connection for complex cardiac anomalies.

Authors:  M Tayama; N Hirata; T Matsushita; T Sano; N Fukushima; Y Sawa; T Nishimura; H Matsuda
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

2.  Heart Failure in Adults who had the Fontan Procedure: Natural History, Evaluation, and Management.

Authors:  Ari Cedars; Susan Joseph; Philip Ludbrook
Journal:  Curr Treat Options Cardiovasc Med       Date:  2013-10

Review 3.  Exercise capacity and impact of exercise training in patients after a Fontan procedure: a review.

Authors:  Patrice Brassard; Elisabeth Bédard; Jean Jobin; Josep Rodés-Cabau; Paul Poirier
Journal:  Can J Cardiol       Date:  2006-05-01       Impact factor: 5.223

4.  Heart rate and oxygen uptake response to exercise in children with low peak exercise heart rate.

Authors:  I M Schulze-Neick; H U Wessel; M H Paul
Journal:  Eur J Pediatr       Date:  1992-03       Impact factor: 3.183

5.  MDCT evaluation of pulmonary embolism in children and young adults following a lateral tunnel Fontan procedure: optimizing contrast-enhancement techniques.

Authors:  Sanjay P Prabhu; Soran Mahmood; Laureen Sena; Edward Y Lee
Journal:  Pediatr Radiol       Date:  2009-05-27

6.  A 4D flow MRI evaluation of the impact of shear-dependent fluid viscosity on in vitro Fontan circulation flow.

Authors:  Andrew L Cheng; Choo Phei Wee; Niema M Pahlevan; John C Wood
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-10-04       Impact factor: 4.733

Review 7.  Impairments in Pulmonary Function in Fontan Patients: Their Causes and Consequences.

Authors:  Karina Laohachai; Julian Ayer
Journal:  Front Pediatr       Date:  2022-04-15       Impact factor: 3.418

8.  Contributions of residual hypoxemia to exercise hyperventilation in Fontan patients.

Authors:  Yukiko Okamura; Machiko Kito; Kazushi Yasuda; Reizo Baba
Journal:  Nagoya J Med Sci       Date:  2020-05       Impact factor: 1.131

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.